BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6305681)

  • 1. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone.
    Ensinger HA
    Eur J Pharmacol; 1983 Apr; 89(1-2):143-7. PubMed ID: 6305681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N; Pasternak GW
    Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW; West RE; Miller RJ; Dawson G
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms.
    Weyhenmeyer JA; Mack KJ
    Neuropharmacology; 1985 Feb; 24(2):111-5. PubMed ID: 2986030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
    Tiberi M; Magnan J
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzomorphan binding sites in rat lumbo-sacral spinal cord.
    Gouardéres C; Audigier Y; Cros J
    Eur J Pharmacol; 1982 Mar; 78(4):483-6. PubMed ID: 6281039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of guanyl nucleotides and ions on kappa opioid binding.
    Mack KJ; Lee MF; Weyhenmeyer JA
    Brain Res Bull; 1985 Apr; 14(4):301-6. PubMed ID: 2988712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution in the receptor binding of putative mu and kappa opiates.
    Medzihradsky F; Dahlstrom PJ; Woods JH; Fischel SV; Mitsos SE
    Life Sci; 1984 May; 34(22):2129-38. PubMed ID: 6145076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human placental opioid receptors by 3H-ethylketocyclazocine and 3H-naloxone binding.
    Agbas A; Simon J; Avni Oktem H; Varga E; Borsodi A
    Neuropeptides; 1988 Oct; 12(3):171-6. PubMed ID: 2907370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
    Fischel SV; Medzihradsky F
    Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of opioid receptor binding in brain slices.
    Barchfeld-Rothschild CC; Medzihradsky F
    J Neurosci Res; 1987; 18(2):358-65. PubMed ID: 2891857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of kappa- and sigma-opiates in rat brain.
    Wolozin BL; Nishimura S; Pasternak GW
    J Neurosci; 1982 Jun; 2(6):708-13. PubMed ID: 6283040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of two different buffers on the high affinity 3H-ethylketocyclazocine and 3H-SKF10047 binding to guinea pig brain membranes.
    Grynne BH; Maurset AR; Holmen AT; Enger M
    Acta Pharmacol Toxicol (Copenh); 1984 Mar; 54(3):195-200. PubMed ID: 6144235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.